A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.
Liu J, Wang L, Kurtesi A, Budylowski P, Potts KG, Menon H, Tan Y, Samaan P, Liu X, Wang Y, Hu Q, Samson R, Qi F, Evseev D, John C, Ellestad KK, Fan Y, Budiman F, Tohan ER, Udayakumar S, Yang J, Marcusson EG, Gingras AC, Mahoney DJ, Ostrowski MA, Martin-Orozco N.
Liu J, et al. Among authors: tan y.
NPJ Vaccines. 2025 Jan 10;10(1):4. doi: 10.1038/s41541-025-01062-8.
NPJ Vaccines. 2025.
PMID: 39788981
Free article.